Diaceutics Reports H1 2026 Financial and Operational Performance

Diaceutics PLC reported a 20% increase in revenue in the first half of 2026. Annual Recurring Revenue reached GBP 29.4 million, with 149% net revenue retention and 6% gross ARR churn. The company said growth is supported by expanding its Precision for All and Relay initiatives, pursuing new pricing opportunities, and using AI to improve operational efficiency.